Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SKRR to Commence Uranium Drill Program to Test Conductors at Clearwater West (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Healthcare
Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

TSXV:CLAS.H - Post Discussion

Claritas Pharmaceuticals Inc > Nitric Oxide
View:
Post by indaknownewfie on Aug 18, 2020 4:18pm

Nitric Oxide

https://www.phe.gov/Preparedness/news/Pages/gsk-chem.aspx
Comment by ETalien on Aug 18, 2020 4:57pm
Why no mention of Kalytera? Why is it that every other therapeutic company are working with a bigger company to further research the use of Nitric oxide in COVID-19 patients? Who is this Radikal Therapeutics that is researching N.O. with GSK?
Comment by Moonshiner592 on Aug 18, 2020 5:08pm
Bro - Think Salzman.... 
Comment by Bigginvestor on Aug 18, 2020 5:19pm
just like glaxosmith and Kline back in 1980 it was trading at pennies hope fully soon this thing will trade at $1 or $2 or HIgh . 40 cents or 50 cents that way I cash the hell out....
Comment by ETalien on Aug 18, 2020 6:02pm
Hey MoonShiner, is Salzman connected someway with/to Radikal? I cannot find the link between the two, dots have escaped me lately...
Comment by Jack4000 on Aug 18, 2020 6:08pm
This post has been removed in accordance with Community Policy
Comment by Jack4000 on Aug 18, 2020 6:09pm
This post has been removed in accordance with Community Policy
Claritas Pharmaceuticals Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities